DUR-928

· Durect Corporation

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DUR-928, covering 2022-08-05 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment [Phase 2]

See pricing